Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello MC, Bosticardo M, Evangelio C, Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow DJ, Galy A, Miniero R, Finocchi A, Metin A, Banerjee PP, Orange JS, Galimberti S, Valsecchi MG, Biffi A, Montini E, Villa A, Ciceri F, Roncarolo MG, Naldini L.

Science. 2013 Aug 23;341(6148):1233151. doi: 10.1126/science.1233151. Epub 2013 Jul 11.

2.

A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells.

McMurchy AN, Gillies J, Gizzi MC, Riba M, Garcia-Manteiga JM, Cittaro D, Lazarevic D, Di Nunzio S, Piras IS, Bulfone A, Roncarolo MG, Stupka E, Bacchetta R, Levings MK.

Blood. 2013 Feb 21;121(8):1265-75. doi: 10.1182/blood-2012-05-431023. Epub 2012 Nov 20.

PMID:
23169781
3.

Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability.

Passerini L, Olek S, Di Nunzio S, Barzaghi F, Hambleton S, Abinun M, Tommasini A, Vignola S, Cipolli M, Amendola M, Naldini L, Guidi L, Cecconi M, Roncarolo MG, Bacchetta R.

J Allergy Clin Immunol. 2011 Dec;128(6):1376-1379.e1. doi: 10.1016/j.jaci.2011.09.010. Epub 2011 Oct 13. No abstract available.

PMID:
22000569
4.

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.

Passerini L, Di Nunzio S, Gregori S, Gambineri E, Cecconi M, Seidel MG, Cazzola G, Perroni L, Tommasini A, Vignola S, Guidi L, Roncarolo MG, Bacchetta R.

Eur J Immunol. 2011 Apr;41(4):1120-31. doi: 10.1002/eji.201040909. Epub 2011 Mar 14.

5.

Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.

Di Nunzio S, Cecconi M, Passerini L, McMurchy AN, Baron U, Turbachova I, Vignola S, Valencic E, Tommasini A, Junker A, Cazzola G, Olek S, Levings MK, Perroni L, Roncarolo MG, Bacchetta R.

Blood. 2009 Nov 5;114(19):4138-41. doi: 10.1182/blood-2009-04-214593. Epub 2009 Sep 8.

PMID:
19738030
6.

Molecular regulation of cellular immunity by FOXP3.

McMurchy AN, Di Nunzio S, Roncarolo MG, Bacchetta R, Levings MK.

Adv Exp Med Biol. 2009;665:30-46. Review.

PMID:
20429414
7.

Surface silver-doping of biocompatible glass to induce antibacterial properties. Part I: Massive glass.

Verné E, Miola M, Vitale Brovarone C, Cannas M, Gatti S, Fucale G, Maina G, Massé A, Di Nunzio S.

J Mater Sci Mater Med. 2009 Mar;20(3):733-40. doi: 10.1007/s10856-008-3617-9. Epub 2008 Nov 6.

PMID:
18987954
8.

Surface silver-doping of biocompatible glasses to induce antibacterial properties. Part II: Plasma sprayed glass-coatings.

Miola M, Ferraris S, Di Nunzio S, Robotti PF, Bianchi G, Fucale G, Maina G, Cannas M, Gatti S, Massé A, Vitale Brovarone C, Verné E.

J Mater Sci Mater Med. 2009 Mar;20(3):741-9. doi: 10.1007/s10856-008-3618-8. Epub 2008 Nov 6.

PMID:
18987953
9.

STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

Passerini L, Allan SE, Battaglia M, Di Nunzio S, Alstad AN, Levings MK, Roncarolo MG, Bacchetta R.

Int Immunol. 2008 Mar;20(3):421-31. doi: 10.1093/intimm/dxn002. Epub 2008 Feb 12.

PMID:
18270368
10.

Surface characterization of silver-doped bioactive glass.

Vernè E, Di Nunzio S, Bosetti M, Appendino P, Brovarone CV, Maina G, Cannas M.

Biomaterials. 2005 Sep;26(25):5111-9.

PMID:
15792537
11.

Macroporous glass-ceramic materials with bioactive properties.

Vitale-Brovarone C, Di Nunzio S, Bretcanu O, Verné E.

J Mater Sci Mater Med. 2004 Mar;15(3):209-17.

PMID:
15334992

Supplemental Content

Loading ...
Support Center